Cargando…

Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial

BACKGROUND: National Health Service Stop Smoking Services (SSSs) offer help to smokers motivated to quit; however, attendance rates are low and recent figures show a downward trend. We aimed to assess the effectiveness of a two-component personalised intervention on attendance at SSSs. METHODS: We d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Hazel, Sutton, Stephen, Morris, Richard, Petersen, Irene, Galton, Simon, Wu, Qi, Parrott, Steve, Nazareth, Irwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357975/
https://www.ncbi.nlm.nih.gov/pubmed/28129989
http://dx.doi.org/10.1016/S0140-6736(16)32379-0
_version_ 1782516148816838656
author Gilbert, Hazel
Sutton, Stephen
Morris, Richard
Petersen, Irene
Galton, Simon
Wu, Qi
Parrott, Steve
Nazareth, Irwin
author_facet Gilbert, Hazel
Sutton, Stephen
Morris, Richard
Petersen, Irene
Galton, Simon
Wu, Qi
Parrott, Steve
Nazareth, Irwin
author_sort Gilbert, Hazel
collection PubMed
description BACKGROUND: National Health Service Stop Smoking Services (SSSs) offer help to smokers motivated to quit; however, attendance rates are low and recent figures show a downward trend. We aimed to assess the effectiveness of a two-component personalised intervention on attendance at SSSs. METHODS: We did this randomised controlled trial in 18 SSSs in England. Current smokers (aged ≥16 years) were identified from medical records in 99 general practices and invited to participate by their general practitioner. Individuals who gave consent, were motivated to quit, and had not attended the SSS within the past 12 months, were randomly assigned (3:2), via computer-generated randomisation with permuted blocks (block size of five), to receive either an individually tailored risk letter and invitation to attend a no-commitment introductory session run by the local SSS (intervention group) or a standard generic letter advertising the local SSS (control group). Randomisation was stratified by sex. Masking of participants to receipt of a personal letter and invitation to a taster session was not possible. The personal letter was generated by a research assistant, but the remainder of the research team were masked to group allocation. General practitioners, practice staff, and SSS advisers were unaware of their patients' allocation. The primary outcome was attendance at the first session of an SSS course within 6 months from randomisation. We did analysis by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN 76561916. FINDINGS: Recruitment, collection of baseline data, delivery of the intervention, and follow up of participants took place between Jan 31, 2011, and July 12, 2014. We randomly assigned 4384 smokers to the intervention group (n=2636) or the control group (n=1748); 4383 participants comprised the intention-to-treat population. Attendance at the first session of an SSS course was significantly higher in the intervention group than in the control group (458 [17·4%] vs 158 [9·0%] participants; unadjusted odds ratio 2·12 [95% CI 1·75–2·57]; p<0·0001). INTERPRETATION: Delivery of personalised risk information alongside an invitation to an introductory session more than doubled the odds of attending the SSS compared with a standard generic invitation to contact the service. This result suggests that a more proactive approach, combined with an opportunity to experience local services, can reduce patient barriers to receiving treatment and has high potential to increase uptake. FUNDING: National Institutes of Health Research Health Technology Assessment.
format Online
Article
Text
id pubmed-5357975
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53579752017-03-28 Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial Gilbert, Hazel Sutton, Stephen Morris, Richard Petersen, Irene Galton, Simon Wu, Qi Parrott, Steve Nazareth, Irwin Lancet Articles BACKGROUND: National Health Service Stop Smoking Services (SSSs) offer help to smokers motivated to quit; however, attendance rates are low and recent figures show a downward trend. We aimed to assess the effectiveness of a two-component personalised intervention on attendance at SSSs. METHODS: We did this randomised controlled trial in 18 SSSs in England. Current smokers (aged ≥16 years) were identified from medical records in 99 general practices and invited to participate by their general practitioner. Individuals who gave consent, were motivated to quit, and had not attended the SSS within the past 12 months, were randomly assigned (3:2), via computer-generated randomisation with permuted blocks (block size of five), to receive either an individually tailored risk letter and invitation to attend a no-commitment introductory session run by the local SSS (intervention group) or a standard generic letter advertising the local SSS (control group). Randomisation was stratified by sex. Masking of participants to receipt of a personal letter and invitation to a taster session was not possible. The personal letter was generated by a research assistant, but the remainder of the research team were masked to group allocation. General practitioners, practice staff, and SSS advisers were unaware of their patients' allocation. The primary outcome was attendance at the first session of an SSS course within 6 months from randomisation. We did analysis by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN 76561916. FINDINGS: Recruitment, collection of baseline data, delivery of the intervention, and follow up of participants took place between Jan 31, 2011, and July 12, 2014. We randomly assigned 4384 smokers to the intervention group (n=2636) or the control group (n=1748); 4383 participants comprised the intention-to-treat population. Attendance at the first session of an SSS course was significantly higher in the intervention group than in the control group (458 [17·4%] vs 158 [9·0%] participants; unadjusted odds ratio 2·12 [95% CI 1·75–2·57]; p<0·0001). INTERPRETATION: Delivery of personalised risk information alongside an invitation to an introductory session more than doubled the odds of attending the SSS compared with a standard generic invitation to contact the service. This result suggests that a more proactive approach, combined with an opportunity to experience local services, can reduce patient barriers to receiving treatment and has high potential to increase uptake. FUNDING: National Institutes of Health Research Health Technology Assessment. Elsevier 2017-02-25 /pmc/articles/PMC5357975/ /pubmed/28129989 http://dx.doi.org/10.1016/S0140-6736(16)32379-0 Text en © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Gilbert, Hazel
Sutton, Stephen
Morris, Richard
Petersen, Irene
Galton, Simon
Wu, Qi
Parrott, Steve
Nazareth, Irwin
Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial
title Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial
title_full Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial
title_fullStr Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial
title_full_unstemmed Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial
title_short Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial
title_sort effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (start2quit): a randomised controlled trial
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357975/
https://www.ncbi.nlm.nih.gov/pubmed/28129989
http://dx.doi.org/10.1016/S0140-6736(16)32379-0
work_keys_str_mv AT gilberthazel effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial
AT suttonstephen effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial
AT morrisrichard effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial
AT petersenirene effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial
AT galtonsimon effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial
AT wuqi effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial
AT parrottsteve effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial
AT nazarethirwin effectivenessofpersonalisedriskinformationandtastersessionstoincreasetheuptakeofsmokingcessationservicesstart2quitarandomisedcontrolledtrial